You're Invited to "Building Better Boards"

Jul 1, 2014

Registration closed 7/22 @ 9am.

Walk-In Registration available for $60.

Sponsored by
B&B MMA LogoAlexandria_web

Join us to find out how to put together a Board of Directors that works for your company!

Who are the right people? How do you get them involved? How do you leverage their expertise? Join us as some of our most experienced CEOs and board members share their insights!
We will be joined by:
David Hale, Hale BioPharma Investments
Jeff Lunsford, Tealium

Ken is both an experienced VC and former executive who built boards.

And with Moderator Rob Kornegay from WSGR
and more to come!
Building Boards
Thursday, July 24, 2014
7:00 AM – 9:00 AM
Hyatt Regency La Jolla 

Registration closed 7/22 @ 9am.
Walk-In Registration available for $60.

About David Hale:
Mr. Hale is chairman and CEO of Hale BioPharma Ventures LLC, a private company focused on the formation and development of biotechnology and specialty pharma, diagnostic and medical device companies. He serves as Executive Chairman of Biocept, Inc., a cancer diagnostic company focused on the detection and analysis of circulating tumor cells. Mr. Hale was formerly president and CEO of CancerVax Corporation, a biotechnology company focused on the development of novel biological products for the treatment of cancer, from October 2000 until its merger with Micromet, Inc. in 2006 when he became chairman of the combined companies. Mr. Hale has previously led some of San Diego’s premiere biotech companies, including as president and CEO of Hybritech, Inc. before it was acquired by Eli Lilly & Co.; and as chairman, president and CEO of Gensia, Inc., through its merger with SICOR to form Gensia Sicor; and as a co-founder and chairman of Viagene, Inc. prior to its acquisition by Chiron Corporation. Mr. Hale also was a founder and currently serves as chairman of Somaxon Pharmaceuticals and serves as chairman of Santarus, Inc., which are publicly held companies. and of the private companies, SkinMedica, Inc., Ridge Diagnostics, Intrepid Therapeutics, Inc and Advantar Laboratories, Inc.
About Jeff Lunsford:
Jeff Lunsford has more than two decades of experience as a technology and Internet executive. Jeff previously served as President, CEO and Chairman at Limelight Networks, which he took public in 2007 as part of a $240M IPO. From 2003-2006, Jeff was the CEO of WebSideStory, a SaaS-based web analytics pioneer that went public in 2004 and is now part of Adobe Systems. Prior to that, Jeff was the CEO of TogetherSoft, a software development tools company that was sold to Borland Software. A former naval aviator, Jeff received a B.S. in Information and Computer Sciences from the Georgia Institute of Technology.